Yosipovitch G, Shohat B, Bshara J, Wysenbeek A, Weinberger A
Department of Medicine B, Beilinson Medical Center, Petah Tikva, Israel.
Isr J Med Sci. 1995 Jun;31(6):345-8.
Soluble interleukin 2 receptor (SIL-2R) and interleukin 1-B (IL-1B) levels in peripheral blood were assayed by enzyme-linked immunoabsorbent method in 25 patients with Behçet's disease and in 20 healthy controls. Eighteen patients suffered from active Behçet's disease and 6 patients had severe disease manifestations. SIL-2R levels were followed for a period of 16 months and were correlated with disease activity. In all the patients with Behçet's disease the levels of SIL-2R and IL-1B were significantly higher than their control, 958 +/- 712 vs. 404 +/- 119 u/ml (P < 0.001) for SIL-2R and 639 +/- 741 vs. 59 +/- 53 pg/ml (P < 0.001) for IL-1B. No correlation was found between disease activity and severity and the levels of SIL-2R and IL-1B. It is suggested that levels of SIL-2R and IL-1B are elevated in patients with Behçet's disease but do not serve as disease activity markers.
采用酶联免疫吸附法检测了25例白塞病患者和20例健康对照者外周血中可溶性白细胞介素2受体(SIL-2R)和白细胞介素1-β(IL-1β)水平。18例患者患有活动期白塞病,6例患者有严重疾病表现。对SIL-2R水平进行了16个月的随访,并将其与疾病活动度相关联。在所有白塞病患者中,SIL-2R和IL-1β水平显著高于对照组,SIL-2R为958±712 vs. 404±119 u/ml(P<0.001),IL-1β为639±741 vs. 59±53 pg/ml(P<0.001)。未发现疾病活动度和严重程度与SIL-2R和IL-1β水平之间存在相关性。提示白塞病患者SIL-2R和IL-1β水平升高,但不作为疾病活动度标志物。